The Readout Loud
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?